translate English to French: A randomized controlled trial of pharmacist-managed oral anticoagulotherapy (PHARMA trial) 3 $43,000 (CIHR/IRSC) $9,649 $129,000 (CIHR/IRSC)$64,899 TARDIF, Jean-Claude Institut de Cardiologie de Montréal Safety and efficacy of AGI-1067 as an agent to prevent post-angioplasty restenosis and coronary atherosclerosis progression 2 $4,902,184 (CIHR/IRSC) $1,241,870 $10,087,195 (CIHR/IRSC) $4,967,480 For information on other studies funded in collaboration with industry, please refer to the CIHR Rx&D and University-Industry Research Programs.
A randomized controlled trial of pharmacist-managed oral anticoagulotherapy (PHARMA trial) 3 $43,000 (CIHR/IRSC) $9,649 $129,000 (CIHR/IRSC)$64,899 TARDIF, Jean-Claude Institut de Cardiologie de Montréal Safety and efficacy of AGI-1067 as an agent to prevent post-angioplasty restenosis and coronary atherosclerosis progression 2 $4,902,184 (CIHR/IRSC) $1,241,870 $10,087,195 (CIHR/IRSC) $4,967,480 Pour obtenir des renseignements sur les autres études financées en collaboration avec l'industrie, veuillez consulter le Programme de recherche Rx&D et le Programme université-industrie.